iBio Inc (IBIO)
1.89
-0.01
(-0.53%)
USD |
NYAM |
Apr 24, 16:00
1.89
0.00 (0.00%)
After-Hours: 19:35
iBio Cash from Investing (TTM): 8.285M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.285M |
September 30, 2023 | 7.03M |
June 30, 2023 | 7.009M |
March 31, 2023 | 7.492M |
December 31, 2022 | -0.232M |
September 30, 2022 | 0.051M |
June 30, 2022 | -5.127M |
March 31, 2022 | -8.512M |
December 31, 2021 | -13.04M |
September 30, 2021 | -25.03M |
June 30, 2021 | -26.48M |
March 31, 2021 | -24.39M |
December 31, 2020 | -20.47M |
September 30, 2020 | -7.724M |
June 30, 2020 | -1.154M |
March 31, 2020 | -0.507M |
December 31, 2019 | -0.55M |
September 30, 2019 | -0.731M |
June 30, 2019 | -0.99M |
March 31, 2019 | -1.099M |
December 31, 2018 | -1.445M |
September 30, 2018 | -1.257M |
June 30, 2018 | -1.079M |
March 31, 2018 | -1.322M |
December 31, 2017 | -1.14M |
Date | Value |
---|---|
September 30, 2017 | -1.102M |
June 30, 2017 | -1.593M |
March 31, 2017 | -1.128M |
December 31, 2016 | -0.828M |
September 30, 2016 | -0.652M |
June 30, 2016 | -0.068M |
March 31, 2016 | -0.071M |
December 31, 2015 | -0.12M |
September 30, 2015 | -0.202M |
June 30, 2015 | -0.215M |
March 31, 2015 | -0.211M |
December 31, 2014 | -0.277M |
September 30, 2014 | -0.231M |
June 30, 2014 | -0.259M |
March 31, 2014 | -0.237M |
December 31, 2013 | -0.166M |
September 30, 2013 | -0.196M |
June 30, 2013 | -0.195M |
March 31, 2013 | -0.2174M |
December 31, 2012 | -0.2339M |
September 30, 2012 | -0.2107M |
June 30, 2012 | -0.245M |
March 31, 2012 | -0.0799M |
December 31, 2011 | -0.0706M |
September 30, 2011 | -0.1165M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-26.48M
Minimum
Jun 2021
8.285M
Maximum
Dec 2023
-5.53M
Average
-0.99M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Lixte Biotechnology Holdings Inc | -- |
PAVmed Inc | 0.758M |
Avalo Therapeutics Inc | -0.133M |
Imunon Inc | 11.01M |
Ocugen Inc | 3.077M |